title: OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation.
abstract: BACKGROUND
  Identification of tumor suppressor genes (TSGs) silenced by CpG methylation uncovers the molecular mechanism of tumorigenesis and potential tumor biomarkers. Loss of heterozygosity at 11q25 is common in multiple tumors including nasopharyngeal carcinoma (NPC). OPCML, located at 11q25, is one of the downregulated genes we identified through digital expression subtraction.
  
  
  RESULTS
  Semi-quantitative RT-PCR showed frequent OPCML silencing in NPC and other common tumors, with no homozygous deletion detected by multiplex differential DNA-PCR. Instead, promoter methylation of OPCML was frequently detected in multiple carcinoma cell lines (nasopharyngeal, esophageal, lung, gastric, colon, liver, breast, cervix, prostate), lymphoma cell lines (non-Hodgkin and Hodgkin lymphoma, nasal NK/T-cell lymphoma) and primary tumors, but not in any non-tumor cell line and seldom weakly methylated in normal epithelial tissues. Pharmacological and genetic demethylation restored OPCML expression, indicating a direct epigenetic silencing. We further found that OPCML is stress-responsive, but this response is epigenetically impaired when its promoter becomes methylated. Ecotopic expression of OPCML led to significant inhibition of both anchorage-dependent and -independent growth of carcinoma cells with endogenous silencing.
  
  
  CONCLUSIONS
  Thus, through functional epigenetics, we identified OPCML as a broad tumor suppressor, which is frequently inactivated by methylation in multiple malignancies.
authors: State Key Laboratory in Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute, Chinese University of Hong Kong, Hong Kong, China.
authors: Yan
authors: Y
authors: Cui
authors: Ying
authors: Y
authors: Ying
authors: Andrew
authors: A
authors: van Hasselt
authors: Ka Man
authors: KM
authors: Ng
authors: Jun
authors: J
authors: Yu
authors: Qian
authors: Q
authors: Zhang
authors: Jie
authors: J
authors: Jin
authors: Dingxie
authors: D
authors: Liu
authors: Johng S
authors: JS
authors: Rhim
authors: Sun Young
authors: SY
authors: Rha
authors: Myriam
authors: M
authors: Loyo
authors: Anthony T C
authors: AT
authors: Chan
authors: Gopesh
authors: G
authors: Srivastava
authors: George S W
authors: GS
authors: Tsao
authors: Grant C
authors: GC
authors: Sellar
authors: Joseph J Y
authors: JJ
authors: Sung
authors: David
authors: D
authors: Sidransky
authors: Qian
authors: Q
authors: Tao
mesh_terms: D017398:Alternative Splicing; D002277:Carcinoma / Q000235:genetics*; D015815:Cell Adhesion Molecules / Q000235:genetics*; D002880:Chromosomes, Human, Pair 11; D019175:DNA Methylation; D044127:Epigenesis, Genetic / Q000235:genetics*; D005260:Female; D058851:GPI-Linked Proteins; D020868:Gene Silencing; D016147:Genes, Tumor Suppressor; D014644:Genetic Variation; D006801:Humans; D019656:Loss of Heterozygosity; D008223:Lymphoma / Q000235:genetics*; D008297:Male; D009303:Nasopharyngeal Neoplasms / Q000235:genetics; D009419:Nerve Tissue Proteins / Q000235:genetics*; D012016:Reference Values; D014158:Transcription, Genetic
chemical_list: D015815:Cell Adhesion Molecules; D058851:GPI-Linked Proteins; D009419:Nerve Tissue Proteins; C059785:OPCML protein, human